Importantly, comprehensive immunological analyses revealed that SPHK1 expression is closely linked to immunosuppressive features across cancers, including altered immune cell infiltration and elevated expression of established immune checkpoint molecules, positioning SPHK1 as a key regulator linking metabolic dysregulation to immune evasion. The gene discussed is SPHK1; the disease is cancer.